Rapid-infusion Isatuximab in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04802031 · WITHDRAWN
Trial details
- NCT number
- NCT04802031
- Sponsor
- Thomas Martin, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2022-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.